Pathology of experimental autoimmune uveoretinitis in mice
References (20)
- et al.
Retinal specific antigens and immunopathogenic processes they provoke
Prog. Retinal Res.
(1986) - et al.
T lymphocyte subsets in experimental autoimmune uveitis
Clin. Immunol. Immunopathol.
(1985) - et al.
Sympathetic ophthalmia: Immunopathologic findings
Ophthalmology
(1986) - et al.
Active experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion
Cell. Immunol.
(1985) - et al.
Retinal vascular endothelium expression fibronectin and class II histocompatibility complex antigens in experimental autoimmune uveitis
Cell. Immunol.
(1987) Autoimmunity and the retina
Curr. Top. Eye Res.
(1980)- et al.
S-antigen uveitis in primates: A new model for human disease
Arch. Ophthalmol.
(1981) - et al.
A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens
J. Immunol.
(1988) - et al.
A new model for experimental autoimmune uveoretinitis (EAU) in the mouse
Invest. Ophthalmol. Vis. Sci.
(1988) - et al.
Isolation and characterization of monkey interphotoreceptor retinoid-binding protein, a unique extracellular matrix component of the retina
Biochemistry
(1985)
There are more references available in the full text version of this article.
Cited by (187)
Blocking the inflammasome: A novel approach to treat uveitis
2021, Drug Discovery TodayInterleukin 35 Regulatory B Cells
2021, Journal of Molecular BiologyCitation Excerpt :However, major cell types that produce IL-35 in vivo and mechanisms that regulate IL-35 production by B cells are poorly understood. Thus, while CD4+ T cells and myeloid cells are the dominant cells recruited into the retina during ocular inflammation [66,67], analysis of the blood, draining LNs, and spleen of mice with EAU revealed ∼ 7-fold increase of IL-10-producing Bregs compared to Tregs or IL-10-secreting myeloid cells [68]. The level of IL-35-expressing Bregs was even higher with significant proportion of the Bregs producing both IL-10 and IL-35 [68].
Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis
2019, Journal of Controlled ReleaseAcid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment
2019, American Journal of Pathology
Copyright © 1990 Published by Elsevier Ltd.